Latest 10-K annual reports
NASDAQ
Avalo Therapeutics reported a significant increase in net loss for 2025, driven by higher R&D and administrative expenses, as it progresses its lead drug candidate, abdakibart, towards a critical Phase 2 data readout in Q2 2026.
AMEX
Idaho Strategic Resources achieved significant financial growth and operational milestones in 2025, driven by increased gold production and strategic advancements in its rare earth element projects.
NYSE
Core Laboratories Inc. reported a slight revenue increase in 2025, driven by service growth, but saw declines in net income and product sales amidst geopolitical conflicts and a challenging international exploration environment.
NASDAQ
ATER
Aterian, INCAterian, Inc. reported significantly increased net losses and negative operating cash flow for 2025, prompting a strategic alternatives review and raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Wellgistics Health reported a significant net loss of $101.3 million for 2025, facing Nasdaq delisting concerns and substantial debt obligations.
NASDAQ
EGH Acquisition Corp. (EGH) filed its annual 10-K report, outlining its financial position, ongoing efforts to merge with Hecate Energy Group, and associated risks and governance structures.
NYSE
VAALCO Energy, Inc. filed an Amendment No. 1 to its Annual Report on Form 10-K to correct a typographical error in the consent of its independent petroleum engineer.
NYSE
AI Infrastructure Acquisition Corp., a SPAC, filed its 2025 annual report, detailing its search for an AI infrastructure target and reporting net income of $1.1 million from interest.
NASDAQ
Vendome Acquisition Corporation I, a blank check company, filed its annual 10-K report for fiscal year 2025, detailing its formation, initial public offering, and ongoing search for a business combination target.
NASDAQ
SINTX Technologies reports a significant revenue decline in 2025 due to a strategic shift away from low-margin OEM contracts towards proprietary silicon nitride biomedical devices, while securing FDA clearance for a new foot and ankle system.
NASDAQ
NMP Acquisition Corp., a SPAC, reported a net income of $1.78 million for 2025, driven by trust account interest, but auditors express substantial doubt about its ability to continue as a going concern without a business combination by January 2027.
NASDAQ
Ascent Solar Technologies, Inc. filed its 2025 Annual Report, revealing continued net losses, significant cash burn from operations, and an auditor's going concern warning, despite an increase in product revenue.
NASDAQ
Creative Medical Technology Holdings, Inc. reported increased net losses for 2025 despite significant clinical trial advancements and successful capital raises, highlighting ongoing R&D investment.
NASDAQ
U.S. GoldMining Inc. reports a positive Preliminary Economic Assessment for its Whistler Gold-Copper Project in Alaska, outlining robust economics and significant mineral resources.
MINM
Minim, INCFiEE, Inc. successfully transitioned from legacy networking hardware to AI-driven digital services, achieving profitability and significant revenue growth in 2025, despite ongoing going concern doubts and internal control weaknesses.
NASDAQ
DNMX
Dynamix CORP IiiDynamix Corporation III, a blank check company, reported its 2025 financial results, highlighting its ongoing search for a business combination in energy and digital infrastructure sectors, with a trust account balance of over $202 million.
OQX
Standard Premium Finance Holdings, Inc. reported significant increases in net income and loan originations for fiscal year 2025, driven by strategic expansion and reduced interest expenses.
Star Equity Holdings, Inc. reported an increased net loss of $6.7 million for 2025, up from $4.8 million in 2024, as it integrated the Star Operating Companies acquisition and navigated challenging market conditions.
NASDAQ
Lightwave Logic reported a reduced net loss in 2025, fueled by increased revenue from licensing and NRE, and bolstered its cash reserves with significant capital raises to fund commercialization efforts targeting 2027 volume production.
NASDAQ
UONE
Urban One, INCUrban One, Inc. reported a significant 16.7% decrease in consolidated net revenue and a 39.4% increase in net loss for the year ended December 31, 2025, alongside substantial impairment charges.
NASDAQ
GrowGeneration Corp. reported a significant reduction in net loss and improved gross profit margins for fiscal year 2025, driven by strategic restructuring and proprietary brand growth, despite a decline in overall net sales.
SWK Holdings Corporation reported a net loss of $2.5 million for the fiscal year ended December 31, 2025, driven by a strategic divestiture of its Pharmaceutical Development segment and increased tax expense.
NASDAQ
Palisade Bio reported positive Phase 1 clinical trial results for its lead IBD drug candidate PALI-2108, secured $127.6 million in financing, and outlined plans for Phase 2 studies in 2026.
NYSE
Chain Bridge Bancorp, Inc. reported a slight decrease in net income for 2025 to $20.2 million, despite significant growth in total assets and deposits, driven by increased investment in securities and a focus on liquidity.
OBLG
Oblong, INCTaoWeave, Inc. has completed its transition to a digital asset treasury company focused on the Bittensor AI ecosystem, reporting a net loss of $6.355 million for the year ended December 31, 2025, despite revenue growth.
NASDAQ
Bluerock Acquisition Corp. files its 10-K, outlining its blank check company structure, IPO details, and significant risks associated with its business combination strategy.
NYSE
Jackson Acquisition Company II, a SPAC focused on healthcare, reported a net income of $9.1 million for 2025 while actively seeking its initial business combination by December 2026.
NYSE
SNOW
Snowflake INCSnowflake Inc. reports strong revenue growth and strategic AI investments for fiscal year 2026, while addressing ongoing net losses and significant legal and competitive risks.
NASDAQ
Mountain Lake Acquisition Corp. II's 10-K filing details its blank check company structure, recent $360 million IPO, and strategy to pursue a business combination by January 2028, while outlining significant risks and potential dilution for public shareholders.
NYSE
Bain Capital GSS Investment Corp. (BCSS) filed its 10-K, detailing its recent $460 million IPO, a working capital deficit, and substantial doubt about its ability to continue as a going concern without a business combination.